These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31915075)

  • 21. A genetically engineered
    Murphy SC; Vaughan AM; Kublin JG; Fishbauger M; Seilie AM; Cruz KP; Mankowski T; Firat M; Magee S; Betz W; Kain H; Camargo N; Haile MT; Armstrong J; Fritzen E; Hertoghs N; Kumar S; Sather DN; Pinder LF; Deye GA; Galbiati S; Geber C; Butts J; Jackson LA; Kappe SHI
    Sci Transl Med; 2022 Aug; 14(659):eabn9709. PubMed ID: 36001680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Development of Whole Sporozoite Vaccines for
    Itsara LS; Zhou Y; Do J; Grieser AM; Vaughan AM; Ghosh AK
    Front Immunol; 2018; 9():2748. PubMed ID: 30619241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defining the antigenic diversity of Plasmodium falciparum apical membrane antigen 1 and the requirements for a multi-allele vaccine against malaria.
    Drew DR; Hodder AN; Wilson DW; Foley M; Mueller I; Siba PM; Dent AE; Cowman AF; Beeson JG
    PLoS One; 2012; 7(12):e51023. PubMed ID: 23227229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole sporozoite immunization with Plasmodium falciparum strain NF135 in a randomized trial.
    van der Boor SC; Alkema M; van Gemert GJ; Teelen K; van de Vegte-Bolmer M; Walk J; van Crevel R; de Mast Q; Ockenhouse CF; Sauerwein RW; McCall MBB
    BMC Med; 2023 Apr; 21(1):137. PubMed ID: 37024868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Within-population genetic diversity of Plasmodium falciparum vaccine candidate antigens reveals geographic distance from a Central sub-Saharan African origin.
    Tanabe K; Mita T; Palacpac NM; Arisue N; Tougan T; Kawai S; Jombart T; Kobayashi F; Horii T
    Vaccine; 2013 Feb; 31(9):1334-9. PubMed ID: 23295064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sporozoite immunization: innovative translational science to support the fight against malaria.
    Richie TL; Church LWP; Murshedkar T; Billingsley PF; James ER; Chen MC; Abebe Y; Natasha Kc ; Chakravarty S; Dolberg D; Healy SA; Diawara H; Sissoko MS; Sagara I; Cook DM; Epstein JE; Mordmüller B; Kapulu M; Kreidenweiss A; Franke-Fayard B; Agnandji ST; López Mikue MA; McCall MBB; Steinhardt L; Oneko M; Olotu A; Vaughan AM; Kublin JG; Murphy SC; Jongo S; Tanner M; Sirima SB; Laurens MB; Daubenberger C; Silva JC; Lyke KE; Janse CJ; Roestenberg M; Sauerwein RW; Abdulla S; Dicko A; Kappe SHI; Sim BKL; Duffy PE; Kremsner PG; Hoffman SL
    Expert Rev Vaccines; 2023; 22(1):964-1007. PubMed ID: 37571809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled Human Malaria Infection of Healthy Adults With Lifelong Malaria Exposure to Assess Safety, Immunogenicity, and Efficacy of the Asexual Blood Stage Malaria Vaccine Candidate GMZ2.
    Dejon-Agobe JC; Ateba-Ngoa U; Lalremruata A; Homoet A; Engelhorn J; Nouatin OP; Edoa JR; Fernandes JF; Esen M; Mouwenda YD; Betouke Ongwe EM; Massinga-Loembe M; Hoffman SL; Sim BKL; Theisen M; Kremsner PG; Adegnika AA; Lell B; Mordmüller B
    Clin Infect Dis; 2019 Sep; 69(8):1377-1384. PubMed ID: 30561539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-Dependent Infectivity of Aseptic, Purified, Cryopreserved Plasmodium falciparum 7G8 Sporozoites in Malaria-Naive Adults.
    Laurens MB; Berry AA; Travassos MA; Strauss K; Adams M; Shrestha B; Li T; Eappen A; Manoj A; Abebe Y; Murshedkar T; Gunasekera A; Richie TL; Lyke KE; Plowe CV; Kennedy JK; Potter GE; Deye GA; Sim BKL; Hoffman SL
    J Infect Dis; 2019 Nov; 220(12):1962-1966. PubMed ID: 31419294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes.
    Sedegah M; Peters B; Hollingdale MR; Ganeshan HD; Huang J; Farooq F; Belmonte MN; Belmonte AD; Limbach KJ; Diggs C; Soisson L; Chuang I; Villasante ED
    PLoS One; 2016; 11(10):e0163026. PubMed ID: 27695088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled Human Malaria Infection with Graded Numbers of
    Langenberg MCC; Wammes LJ; McCall MBB; Bijker EM; van Gemert GJ; Graumans W; van de Vegte-Bolmer MG; Teelen K; Hermsen CC; Koelewijn R; van Hellemond JJ; van Genderen PJJ; Sauerwein RW
    Am J Trop Med Hyg; 2018 Sep; 99(3):709-712. PubMed ID: 30014816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development.
    Inoue M; Tang J; Miyakoda M; Kaneko O; Yui K; Culleton R
    Int J Parasitol; 2012 Aug; 42(9):859-70. PubMed ID: 22846785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine.
    Zeeshan M; Alam MT; Vinayak S; Bora H; Tyagi RK; Alam MS; Choudhary V; Mittra P; Lumb V; Bharti PK; Udhayakumar V; Singh N; Jain V; Singh PP; Sharma YD
    PLoS One; 2012; 7(8):e43430. PubMed ID: 22912873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination with chemically attenuated Plasmodium falciparum asexual blood-stage parasites induces parasite-specific cellular immune responses in malaria-naïve volunteers: a pilot study.
    Stanisic DI; Fink J; Mayer J; Coghill S; Gore L; Liu XQ; El-Deeb I; Rodriguez IB; Powell J; Willemsen NM; De SL; Ho MF; Hoffman SL; Gerrard J; Good MF
    BMC Med; 2018 Oct; 16(1):184. PubMed ID: 30293531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults.
    Ogwang C; Afolabi M; Kimani D; Jagne YJ; Sheehy SH; Bliss CM; Duncan CJ; Collins KA; Garcia Knight MA; Kimani E; Anagnostou NA; Berrie E; Moyle S; Gilbert SC; Spencer AJ; Soipei P; Mueller J; Okebe J; Colloca S; Cortese R; Viebig NK; Roberts R; Gantlett K; Lawrie AM; Nicosia A; Imoukhuede EB; Bejon P; Urban BC; Flanagan KL; Ewer KJ; Chilengi R; Hill AV; Bojang K
    PLoS One; 2013; 8(3):e57726. PubMed ID: 23526949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The malaria candidate vaccine liver stage antigen-3 is highly conserved in Plasmodium falciparum isolates from diverse geographical areas.
    Prieur E; Druilhe P
    Malar J; 2009 Oct; 8():247. PubMed ID: 19874576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants.
    Bustamante LY; Bartholdson SJ; Crosnier C; Campos MG; Wanaguru M; Nguon C; Kwiatkowski DP; Wright GJ; Rayner JC
    Vaccine; 2013 Jan; 31(2):373-9. PubMed ID: 23146673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptome profiling reveals functional variation in Plasmodium falciparum parasites from controlled human malaria infection studies.
    Hoo R; Bruske E; Dimonte S; Zhu L; Mordmüller B; Sim BKL; Kremsner PG; Hoffman SL; Bozdech Z; Frank M; Preiser PR
    EBioMedicine; 2019 Oct; 48():442-452. PubMed ID: 31521613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The whole parasite, pre-erythrocytic stage approach to malaria vaccine development: a review.
    Epstein JE; Richie TL
    Curr Opin Infect Dis; 2013 Oct; 26(5):420-8. PubMed ID: 23982233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global diversity of the gene encoding the Pfs25 protein-a Plasmodium falciparum transmission-blocking vaccine candidate.
    Sookpongthai P; Utayopas K; Sitthiyotha T; Pengsakul T; Kaewthamasorn M; Wangkanont K; Harnyuttanakorn P; Chunsrivirot S; Pattaradilokrat S
    Parasit Vectors; 2021 Nov; 14(1):571. PubMed ID: 34749796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring immunological mechanisms of the whole sporozoite vaccination against P. falciparum malaria.
    Mo AX; Pesce J; Hall BF
    Vaccine; 2015 Jun; 33(25):2851-7. PubMed ID: 25917675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.